SWING IDEA - CAPLIN POINT LABORATORIES

Updated
Caplin Point Laboratories, a leading pharmaceutical company known for its strong presence in regulated and emerging markets, presents a promising swing trade opportunity based on the following technical factors:

Reasons are listed below :
  • 2100 Resistance Break: The stock has decisively broken the 2100 resistance level, signaling strength and potential for further upside.
  • Head and Shoulder Pattern Breakout: A classic bullish reversal pattern, indicating a continuation of the uptrend.
  • Bullish Marubozu Candle: A strong bullish candle on the daily timeframe showcases significant buying interest and momentum.
  • Trading Above Key Moving Averages: The price is comfortably above the 50 and 200 EMAs on the daily timeframe, reinforcing the bullish sentiment.


Target - 2390 // 2600
Stoploss - daily close below 2060

DISCLAIMER -

Decisions to buy, sell, hold or trade in securities, commodities and other investments involve risk and are best made based on the advice of qualified financial professionals. Any trading in securities or other investments involves a risk of substantial losses. The practice of "Day Trading" involves particularly high risks and can cause you to lose substantial sums of money. Before undertaking any trading program, you should consult a qualified financial professional. Please consider carefully whether such trading is suitable for you in light of your financial condition and ability to bear financial risks. Under no circumstances shall we be liable for any loss or damage you or anyone else incurs as a result of any trading or investment activity that you or anyone else engages in based on any information or material you receive through TradingView or our services.

@visionary.growth.insights


Trade closed: target reached
1st target achieved : 9%++
Note
made a high of 13%
Note
new all time high daily close!
alltimehighcaplinpointChart PatternsEMASEquityTechnical IndicatorsnsepriceactionanalysisswingtradingTechnical AnalysisTrend Analysis

Related publications

Disclaimer